Search Results - Srividya Sriskantharajah
- Showing 1 - 6 results of 6
-
1
-
2
-
3
-
4
-
5
Safety, pharmacokinetics and dose-response characteristics of GSK2269557, an inhaled PI3Kδ inhibitor under development for the treatment of COPD by Anthony Cahn, J. Hamblin, Malcolm Begg, Robert C. Wilson, L. Dunsire, Srividya Sriskantharajah, Mickaël Montembault, Claudia Leemereise, Laura Galinanes-Garcia, Henrik Watz, Anne‐Marie Kirsten, Rainard Fuhr, Edith M. Hessel
Published 2017Artigo -
6
PI3Kδ hyper-activation promotes development of B cells that exacerbate Streptococcus pneumoniae infection in an antibody-independent manner by Anne‐Katrien Stark, Anita Chandra, Krishnendu Chakraborty, Rafeah Alam, Valentina Carbonaro, Jonathan Clark, Srividya Sriskantharajah, Glyn Bradley, Alex Richter, Edward Banham-Hall, Menna R. Clatworthy, Sergey Nejentsev, J. Hamblin, Edith M. Hessel, Alison M. Condliffe, Klaus Okkenhaug
Published 2018Artigo
Search Tools:
Related Subjects
Biology
Medicine
Cell biology
Internal medicine
Signal transduction
Immunology
PI3K/AKT/mTOR pathway
Biochemistry
COPD
Cancer
Inflammation
Receptor
ASK1
Adverse effect
Alternative medicine
Anatomy
Anesthesia
Antibiotics
Antibody
Autoimmunity
Breast cancer
Cancer research
Cartilage
Chemokine
Endochondral ossification
Endocrinology
Genetics
Hormone receptor
Immune dysregulation
Immune system